Vascular Biogenics Ltd is a clinical-stage bio-pharmaceutical company committed to the discovery, development and commercialization of first-in-class treatments for cancer and immune-inflammatory diseases.
$1.78
As of 04/14/2021 IEX book CBOE book
2021 © Stock Market MBA, Inc.